Jean-Philippe Baguet, Olivier Ormezzano, Gilles Barone-RochetteClinique de Cardiologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, FranceAbstract: Telmisartan, a selective angiotensin II type 1 receptor blocker (ARB), has been investigated in many trials, in particular, in order to assess its antihypertensive effect in various situations and its ability to protect organs susceptible to hypertension. In addition to its antihypertensive properties, it has positive metabolic and vascular effects (partly because of its sustained action). Several large-scale trials have focused on the effect of telmisartan on cardiovascular morbidity and mortality, including comparisons of that with an angiotens-inconverting enzyme inhibitor in subj...
Giuseppe Mancia1, Helmut Schumacher21Universita degli Studi Milano-Bicocca, Ospedale San Gerardo di ...
Angiotensin II induces inflammatory activation of vascular smooth muscle cells and can cause left ve...
Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular events, but are not toler...
Philippe R Akhrass, Samy I McFarlaneState University of New York, Downstate Medical Center, Brooklyn...
Blockade of the renin-angiotensin system is an important approach in managing high blood pressure, a...
Blockade of the renin–angiotensin system is an important approach in managing high blood pressure, ...
The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET()) sh...
Angiotensin II receptor blockers (ARBs) inhibit the renin-angiotensin system. As a result, these age...
Background:In the Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovasc...
Angiotensin-converting enzyme (ACE) inhibitors reduce mortality, myocardial infarction, stroke, hear...
C Venkata S RamTexas Blood Pressure Institute, Clinical Research Institute of Dallas Nephrology Asso...
Bodh I JugduttDivision of Cardiology, Department of Medicine, University of Alberta and Hospital, Ed...
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers reduce ...
Blockade of the renin-angiotensin system (RAS) has become an integral component of the treatment of ...
Marco Ladino, Ivonne Hernandez SchulmanNephrology-Hypertension Section, Veterans Affairs Medical Cen...
Giuseppe Mancia1, Helmut Schumacher21Universita degli Studi Milano-Bicocca, Ospedale San Gerardo di ...
Angiotensin II induces inflammatory activation of vascular smooth muscle cells and can cause left ve...
Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular events, but are not toler...
Philippe R Akhrass, Samy I McFarlaneState University of New York, Downstate Medical Center, Brooklyn...
Blockade of the renin-angiotensin system is an important approach in managing high blood pressure, a...
Blockade of the renin–angiotensin system is an important approach in managing high blood pressure, ...
The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET()) sh...
Angiotensin II receptor blockers (ARBs) inhibit the renin-angiotensin system. As a result, these age...
Background:In the Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovasc...
Angiotensin-converting enzyme (ACE) inhibitors reduce mortality, myocardial infarction, stroke, hear...
C Venkata S RamTexas Blood Pressure Institute, Clinical Research Institute of Dallas Nephrology Asso...
Bodh I JugduttDivision of Cardiology, Department of Medicine, University of Alberta and Hospital, Ed...
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers reduce ...
Blockade of the renin-angiotensin system (RAS) has become an integral component of the treatment of ...
Marco Ladino, Ivonne Hernandez SchulmanNephrology-Hypertension Section, Veterans Affairs Medical Cen...
Giuseppe Mancia1, Helmut Schumacher21Universita degli Studi Milano-Bicocca, Ospedale San Gerardo di ...
Angiotensin II induces inflammatory activation of vascular smooth muscle cells and can cause left ve...
Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular events, but are not toler...